SKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML
Product details
Registration number: SIN16869P
Classification: Prescription Only
Active ingredients: Risankizumab
Strength: 600mg/10mL
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Registrant: ABBVIE PTE. LTD.
ATC code: L04AC18
HSA approval date: 27 September 2023
Manufacturer(s):
- Patheon Italia S.P.A. (Bulk Production and Primary Packager)
- AbbVie Ireland NL B.V
Manufacturing country/countries: ITALY; IRELAND
What are the HSA registration number and classification for SKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16869P
Classification: Prescription Only
What active ingredients and strength are recorded for SKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Risankizumab
Strength: 600mg/10mL
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for SKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for SKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML?
According to the HSA dataset updated 7 August 2026:
Registrant: ABBVIE PTE. LTD.
Which manufacturers and countries are listed for SKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Patheon Italia S.P.A. (Bulk Production and Primary Packager)
- AbbVie Ireland NL B.V
Manufacturing country/countries: ITALY; IRELAND
Where can I look up SKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16869P or the exact product name SKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML. The general register link does not preselect this product.
What are the source dates for this SKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this SKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16869P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)